We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




Tomosynthesis Application More Sensitive Than Chest X-Ray Detecting Lung Nodules

By HospiMedica International staff writers
Posted on 16 Jan 2014
A new tomosynthesis tool provides enhanced detection and management of lung cancer patients and is 7.5 times more sensitive than chest X-ray without decreased specificity in identifying patients who require follow-up.

GE Healthcare’s (Chalfont St. More...
Giles, UK) new clinical application for its fixed radiographic system, VolumeRAD, offers improved detection and management of patients with lung nodules compared to conventional X-ray imaging of the chest. As the first thoracic radiographic tomosynthesis product with a specific indication, this application is designed to improve the detection of lung nodules and the subsequent management of patients.

VolumeRAD provides physicians with multiple high-resolution slice images of the anatomy of interest, including the chest, abdomen, extremities, and spine. This clinical feature is a method of acquiring a series of low-dose projection images during a single sweep of the X-ray tube over a limited angle.

“We are very excited by these results that clearly show the benefit of radiographic tomosynthesis vs conventional X-ray,” said Michelle Edler, general manager of radiology and fluoroscopy for GE’s detection and guidance solutions business. “Customers who use this technology will be able to detect more, and will benefit 360% greater sensitivity without any reduction in specificity, for lung nodules 3–20 mm in diameter. The potential of VolumeRAD as a high-quality, cost-effective, and low dose imaging alternative for lung nodule detection is massive.”

Dr Gautham Reddy, professor of radiology and vice chair for education and director of thoracic imaging in the department of radiology at the University of Washington (Seattle, USA) believes VolumeRAD can offer an intermediate solution for patient care. “Rather than simply getting a CT, we can do a VolumeRAD to verify whether it’s a nodule or not. [For] something that has low likelihood of being a nodule, VolumeRAD will probably exclude the possibility of a nodule and there won’t be as much radiation,” said Dr. Reddy. “That is one of the reasons why VolumeRAD would be helpful. We could get more information than with a [radiograph and] without as much radiation as a CT.”

VolumeRAD generates diagnostic chest images that enable radiologists to detect small lung nodules with superior sensitivity vs. posterior-anterior (PA) and left lateral views of the chest at minimal relative radiation level (< 0.1 mSv). This clinical feature is a way of acquiring a series of low-dose projection images during a single sweep of the X-ray tube over a limited angle.

As many as 60 images can be captured in approximately 10 seconds. These data are then used to generate images at the desired slice interval defined by the user, a huge dose and patient throughput benefit compared to linear tomography, which provides only one image from a similar tube sweep. Using CT-like algorithms, high-resolution thin slices are reconstructed and can be reviewed by the radiologist at a computer workstation as individual images or in a cine mode.

Related Links:

GE Healthcare



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hybrid Arch Device
Neo EDE
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.